📰 Ryne Bio News
Ryne Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ryne Bio. Real-time updates on events, politics, business and more.
February 29, 2024
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
February 29, 2024
Kenai Therapeutics a biotechnology company leveraging induced pluripotent stem cell iPSC technology to discover and develop a platform of allogeneic neuron replacement cell therapies for neurological disorders today announced an 82 million Series A financing coled by Alaska Permanent Fund Corporation Cure Ventures and The Column Group with participation from Euclidean Capital and Saisei Ventures.
April 27, 2023
Global Dopamine Cell Replacement Therapy Clinical Trials, Companies & Market Trends Insight 2023 Report Highlights: Research Methodology Global
March 24, 2023
Among African American cancer survivors, experiencing discrimination is associated with deficit accumulation.
February 15, 2023
Ryne Biotechnology has received a $4m CLIN1 grant from the California Institute for Regenerative Medicine (CIRM) to advance its lead candidate RNDP-001.
February 14, 2023
San Diego-based Ryne Biotechnology, a company developing stem cell technology to treat neurological disorders, says it has received a $4M grant from the California Institute for Regenerative Medicine (CIR
February 14, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!